MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA can downregulate the expression of multiple genes involved in diverse functions. Because cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma (GBM), this review provides an up-to-date summary of miRNA biogenesis, the role of miRNA in cancer resistance, and essential tools for modulating miRNA expression, as well as of clinically promising RNAi delivery systems and how they can be adapted for therapy.
A lire aussi
2025, May 16: seminar of Mickaël Baqué
29 April 2025
par Laetitia Legoupil
A butterfly peptide to combat resistant fungi
16 April 2025
par Laetitia Legoupil
Marcin Suskiewicz, winner of funding from the Human Frontier Science Program, a prestigious international organisation
16 April 2025
par Laetitia Legoupil